Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00058942 · ClinicalTrials.gov registry record · NA
A Trial of Tap Water Treatment in the Elderly
A NA study of Diarrhea and Gastrointestinal Diseases, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- NA
- Development phase
- 810
- Enrollment target
- 1
- Study location
NCT00058942: Completed NA study of Diarrhea and Gastrointestinal Diseases, sponsored by National Institute on Aging (NIA).
NCT00058942 is a NA study of Diarrhea and Gastrointestinal Diseases that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 810 participants, above the 123-participant average among 24 other Diarrhea trials with a reported enrollment target (559% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00058942, a NA study of Diarrhea and Gastrointestinal Diseases, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- NA
- Development phase
- 810 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted in Sonoma County, California. Gastrointestinal illness and diarrhea are recognized as a significant cause of morbidity and mortality in the elderly. One study showed that 51% of deaths caused by diarrhea over a 9-year period occurred in individuals over the age of 74 years. Although many infectious diseases are more problematic in the elderly because of a decline in immune function and a higher incidence of pre-existing malnutrition and dehydration, it is still not known what the principal modes of transmission are and which infectious agents are responsible. The principal objective of this study is to evaluate the ability of in-home treatment of tapwater to reduce gastrointestinal illness in non-institutionalized elderly individuals. The trial will test household-level treatment of drinking water by joint use of ultraviolet light and filtration devices. A secondary objective is an estimate of the incidence of specific bacterial, viral, and protozoan agents in stool specimens collected from elderly individuals with gastrointestinal symptoms that might be related to water consumption.
Conditions Studied
Interventions
- DEVICE home drinking water treatment device
Study Locations (1)
California
- University of California Berkeley - Berkeley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 810 participants |
| Start Date | 2000-01 |
| Est. Completion | 2006-11 |
| Phase | NA |
What the finished NCT00058942 record still lists
NCT00058942 is an interventional study that assigns participants to a tested intervention. The registered 810 participants enrollment target is mid-sized for trials with a published cap, above the 123-participant average among 24 other Diarrhea trials with a reported enrollment target (559% higher).
The record links to 2 conditions, with Diarrhea appearing as the primary indexed condition, and to 1 intervention - of which home drinking water treatment device is the first listed.
NCT00058942 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00058942 about?
NCT00058942 is a clinical study titled "A Trial of Tap Water Treatment in the Elderly". This study is being conducted in Sonoma County, California. Gastrointestinal illness and diarrhea are recognized as a significant cause of morbidity and mortality in the elderly. One study showed that 51% of deaths caused by diarrhea over a 9-year period occurred in individuals over the age of 74 y...
What is the current status of trial NCT00058942?
This trial is currently completed. It is a NA study. The enrollment target is 810 participants. The study started on 2000-01. Estimated completion is 2006-11.
What conditions does trial NCT00058942 study?
This clinical trial studies the following conditions: Diarrhea, Gastrointestinal Diseases.
What interventions are being tested in trial NCT00058942?
The interventions under investigation include: home drinking water treatment device (DEVICE).
Who is sponsoring clinical trial NCT00058942?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00058942 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diarrhea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00058942's enrollment target sits among peer trials
810 2nd of 24 the highest of 24 other Diarrhea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diarrhea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
GI Alpha-Gal Study
RECRUITING · NA
-
Wells and Enteric Disease Transmission
ACTIVE NOT RECRUITING · NA
-
Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor
COMPLETED · NA
-
Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform
COMPLETED · NA
-
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
RECRUITING · Phase 4
-
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05519085 · 810 participants · Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- NCT06529094 · 808 participants · NA
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia